BIXTONIM 5mg / 0.2mg / 1mg / ml nose drops solution medication leaflet

R01AD60 ephedrine hydrochloride + hydrocortisone + naphazoline • Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids

The combination of ephedrine hydrochloride, hydrocortisone, and naphazoline is used in certain preparations to reduce inflammation, congestion, and relieve symptoms associated with upper respiratory tract conditions such as rhinitis or sinusitis. Ephedrine hydrochloride helps open the airways, hydrocortisone reduces inflammation, and naphazoline acts as a decongestant.

This type of treatment is usually administered as nasal drops or spray, as directed by the doctor. It is important for patients not to exceed the recommended dose and not to use the product long-term without medical advice.

Side effects may include dryness of the nasal mucosa, local irritation, palpitations, or increased blood pressure. In rare cases, allergic reactions or worsening of symptoms may occur if the treatment is overused.

The combination of ephedrine hydrochloride, hydrocortisone, and naphazoline is effective for rapid symptom relief, but its use should be limited and supervised by a doctor to prevent complications.

General data about BIXTONIM 5mg / 0.2mg / 1mg / ml

Substance: ephedrine hydrochloride + hydrocortisone + naphazoline

Date of last drug list: 01-07-2013

Commercial code: W12993002

Concentration: 5mg / 0.2mg / 1mg / ml

Pharmaceutical form: nose drops solution

Packing volume: 10ml

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: BIOFARM SA - ROMANIA

Holder: BIOFARM SA - ROMANIA

Number: 11715/2019/01

Shelf life: 18 months; After first opening the bottle. - 30 days

Other substances similar to ephedrine hydrochloride + hydrocortisone + naphazoline